NV-294 Microbiome Therapy Trial for Recurrent C. difficile Infection

The National Library of Medicine added a new clinical trial registration for NV-294, an investigational microbiome therapeutic, to ClinicalTrials.gov. The trial (NCT07519686) will study the safety and efficacy of NV-294 in adults with recurrent C. difficile infection.

For sponsors and clinical investigators, this registration highlights ongoing development of microbiome-based therapies for C. difficile, an area of active clinical research. Entities conducting similar trials should ensure timely registration and results posting on ClinicalTrials.gov to maintain compliance with NIH requirements.